Research Organizations Face Funding Threat Following Trump Treatment
What happened
Donald Trump received monoclonal antibody treatment on October 15, 2026. A report noted that the research organization where the author's son works may lose its funding. These organizations manage clinical trials for infectious diseases, including the treatment used on Donald Trump.
From dailygazette.com
Why it matters
The four large research organizations that test vaccines and treatments for infectious diseases cost $300 million annually. If these organizations are defunded, the clinical trial networks they built could be lost, requiring expensive and difficult rebuilding should a new pathogen emerge.
From dailygazette.com
Who's involved
- Donald TrumpRecipient of monoclonal antibody treatment
- Centers for Disease ControlGovernmental medical research institute whose resources were previously interfered with by Donald Trump's administration
Possible ripples
Who this could reach next, traced step by step from the reporting. Possibilities worth considering, not forecasts.- Funding cuts to US research networks may strain global health cooperationFunding cuts to US research networks may strain global health cooperation with WHOPossible
- Funding cuts could strain FDA's ability to oversee treatmentsWeakening medical research infrastructure may compromise FDA's regulatory oversightPossible
- Research funding cuts may impact Harvard's public health data flowHarvard University's public health data flow may be compromised by research funding cutsPossible
- Potential research cuts may strain Department of Health & Human ServicesPotential research cuts may strain Department of Health & Human ServicesPossible
Keep exploring
The entities involved
-
Donald Trump
American businessman and politician (born 1946), President of the United States (2017–2021; since 2025)
-
Centers for Disease Control
governmental medical research institute with headquarters in Taipei, Taiwan